Migliori GB - Search Results

1

Recommendations for treating children with drug-resistant tuberculosis.

Galli L, Lancella L, Garazzino S, Tadolini M, Matteelli A, Migliori GB, Principi N, Villani A, Esposito S; Italian Pediatric TB Study Group. Galli L, et al. Among authors: migliori gb. Pharmacol Res. 2016 Mar;105:176-82. doi: 10.1016/j.phrs.2016.01.020. Epub 2016 Jan 26. Pharmacol Res. 2016. PMID: 26821118 Review.

2

Multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis: epidemiology and control.

Matteelli A, Migliori GB, Cirillo D, Centis R, Girard E, Raviglion M. Matteelli A, et al. Among authors: migliori gb. Expert Rev Anti Infect Ther. 2007 Oct;5(5):857-71. doi: 10.1586/14787210.5.5.857. Expert Rev Anti Infect Ther. 2007. PMID: 17914919 Review.

3

Extensively drug-resistant (XDR) tuberculosis: an old and new threat.

Fattorini L, Migliori GB, Cassone A. Fattorini L, et al. Among authors: migliori gb. Ann Ist Super Sanita. 2007;43(4):317-9. Ann Ist Super Sanita. 2007. PMID: 18209265 Review.

4

Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results.

Migliori GB, Lange C, Girardi E, Centis R, Besozzi G, Kliiman K, Ortmann J, Matteelli A, Spanevello A, Cirillo DM; SMIRA/TBNET Study Group. Migliori GB, et al. Clin Infect Dis. 2008 Mar 15;46(6):958-9. doi: 10.1086/528875. Clin Infect Dis. 2008. PMID: 18288911 Free article. No abstract available.

5

Diagnosis of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: Current standards and challenges.

Migliori GB, Matteelli A, Cirillo D, Pai M. Migliori GB, et al. Can J Infect Dis Med Microbiol. 2008 Mar;19(2):169-72. doi: 10.1155/2008/857901. Can J Infect Dis Med Microbiol. 2008. PMID: 19352448 Free PMC article.

6

Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.

Sotgiu G, Lange C, Richardson MD, Matteelli A, Centis R, Eker B, Guenther G, Spanevello A, Migliori GB; TBNET. Sotgiu G, et al. Among authors: migliori gb. J Antimicrob Chemother. 2009 Oct;64(4):879-83; author reply 883-4. doi: 10.1093/jac/dkp265. Epub 2009 Aug 3. J Antimicrob Chemother. 2009. PMID: 19651787 No abstract available.

7

Molecular detection of rifampin and isoniazid resistance to guide chronic TB patient management in Burkina Faso.

Miotto P, Saleri N, Dembelé M, Ouedraogo M, Badoum G, Pinsi G, Migliori GB, Matteelli A, Cirillo DM. Miotto P, et al. Among authors: migliori gb. BMC Infect Dis. 2009 Aug 28;9:142. doi: 10.1186/1471-2334-9-142. BMC Infect Dis. 2009. PMID: 19715569 Free PMC article.

8

Multidrug-resistant and extensively drug-resistant tuberculosis in the West. Europe and United States: epidemiology, surveillance, and control.

Migliori GB, D'Arcy Richardson M, Sotgiu G, Lange C. Migliori GB, et al. Clin Chest Med. 2009 Dec;30(4):637-65, vii. doi: 10.1016/j.ccm.2009.08.015. Clin Chest Med. 2009. PMID: 19925959 Review.

9

Emerging epidemic of drug-resistant tuberculosis in Europe, Russia, China, South America and Asia: current status and global perspectives.

Migliori GB, Centis R, Lange C, Richardson MD, Sotgiu G. Migliori GB, et al. Curr Opin Pulm Med. 2010 May;16(3):171-9. doi: 10.1097/MCP.0b013e328337573e. Curr Opin Pulm Med. 2010. PMID: 20134324 Review.

10

Drug-resistant tuberculosis: past, present, future.

Chiang CY, Centis R, Migliori GB. Chiang CY, et al. Among authors: migliori gb. Respirology. 2010 Apr;15(3):413-32. doi: 10.1111/j.1440-1843.2010.01738.x. Epub 2010 Mar 19. Respirology. 2010. PMID: 20337989 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

575 results

Search Page